Who has invested in Abalos Therapeutics?

No investors are named on the public record for Abalos Therapeutics yet.

Abalos Therapeutics Funding: $47M Raised, Series A

Abalos Therapeutics funding overview

Abalos Therapeutics is based in Düsseldorf, Germany. Abalos Therapeutics has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A.

Abalos Therapeutics at a glance

Total raised: $47M
Latest round: Series A
Headquarters: Düsseldorf, Germany

Frequently asked about Abalos Therapeutics funding

How much has Abalos Therapeutics raised?: Abalos Therapeutics has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Abalos Therapeutics?: No investors are named on the public record for Abalos Therapeutics yet.
What was the latest Abalos Therapeutics funding round?: The most recent disclosed round is a Series A.
Where is Abalos Therapeutics based?: Abalos Therapeutics is based in Düsseldorf, Germany.

Round data for Abalos Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Düsseldorf and backer lists below.

Abalos Therapeutics Funding: $47M Raised, Series A

Abalos Therapeutics funding overview

Abalos Therapeutics at a glance

Frequently asked about Abalos Therapeutics funding

Companies related to Abalos Therapeutics (34)

Browse related funding lists (2)